Identifying determinants of pathologic complete response in patients with breast cancer after receiving neoadjuvant systemic therapy

被引：0
|
作者：
Chan, Abigail Sy
Bhargava, Anika
Chandler, Natasha
Tavcar, Michelle
Gunaratnam, Bakeerathan
Dong, Brian
机构：
[1] Univ Louisville, Louisville, KY USA
[2] Univ Louisville, Sch Med, Louisville, KY USA
[3] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12622
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Relationship Between Breast and Axillary Pathologic Complete Response in Women Receiving Neoadjuvant Chemotherapy for Breast Cancer
    David W. Lim
    Brittany D. Greene
    Nicole J. Look Hong
    Annals of Surgical Oncology, 2021, 28 : 5495 - 5506
  • [42] Pathologic Complete Response in HER2-Positive Breast Cancer Patients Receiving Trastuzumab in Neoadjuvant Setting
    Sheikh, Fareeha
    Nazir, Adil
    Yasmeen, Samia
    Badar, Farhana
    Ahmad, Usman
    Siddiqui, Neelam
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (02): : 159 - 163
  • [43] Laboratory indicators predict axillary nodal pathologic complete response after neoadjuvant therapy in breast cancer
    Chen, Peng
    Zhao, Tong
    Bi, Zhao
    Zhang, Zhao-Peng
    Xie, Li
    Liu, Yan-Bing
    Song, Xing-Guo
    Song, Xian-Rang
    Wang, Chun-Jian
    Wang, Yong-Sheng
    FUTURE ONCOLOGY, 2021, 17 (19) : 2449 - 2460
  • [44] Can axillary surgery be omitted in patients with breast pathologic complete response after neoadjuvant systemic therapy for breast cancer? A real-world retrospective study in China
    Chen, Rui
    Li, Shuo
    Li, Yan
    Zhu, Qiannan
    Shi, Xiaoqing
    Xu, Lu
    Xu, Yinggang
    Zhang, Weiwei
    Huang, Xiaofeng
    Wang, Jue
    Zha, Xiaoming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (12) : 3495 - 3501
  • [45] Can axillary surgery be omitted in patients with breast pathologic complete response after neoadjuvant systemic therapy for breast cancer? A real-world retrospective study in China
    Rui Chen
    Shuo Li
    Yan Li
    Qiannan Zhu
    Xiaoqing Shi
    Lu Xu
    Yinggang Xu
    Weiwei Zhang
    Xiaofeng Huang
    Jue Wang
    Xiaoming Zha
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 3495 - 3501
  • [46] Pathologic complete response after neoadjuvant chemotherapy in breast cancer molecular subtypes
    Sari, E.
    Aksoy, S.
    Dogan, M.
    Altinbas, M.
    Zengin, N.
    Ozisik, Y.
    Altundag, K.
    BREAST, 2015, 24 : S99 - S99
  • [47] Pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy
    Montemurro, Filippo
    Di Cosimo, Serena
    BREAST, 2014, 23 (05): : 690 - 691
  • [48] Surgical considerations for breast cancer patients receiving neoadjuvant systemic therapy
    Hunt, Kelly K.
    Mittendorf, Elizabeth A.
    BREAST CANCER MANAGEMENT, 2013, 2 (05) : 385 - 395
  • [49] URINARY CORRELATES OF PATHOLOGIC COMPLETE RESPONSE IN BLADDER CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY
    Abbosh, Philip
    Liu, David
    Ibragimova, Ilsiya
    Rosenberg, Jonathan
    Ford, James
    El-Deiry, Wafik
    Parker, Daniel
    Geynisman, Daniel
    Alpaugh, R. Katherine
    Cairns, Paul
    Kutikov, Alexander
    Van Allen, Eliezer
    Plimack, Elizabeth
    JOURNAL OF UROLOGY, 2018, 199 (04): : E528 - E529
  • [50] CEA - A Predictor for Pathologic Complete Response After Neoadjuvant Therapy for Rectal Cancer
    Wallin, Ulrik
    Rothenberger, David
    Lowry, Ann
    Luepker, Russell
    Mellgren, Anders
    DISEASES OF THE COLON & RECTUM, 2013, 56 (07) : 859 - 868
12345